Pervasive phosphorylation by phage T7 kinase disarms bacterial defences

Patients with antibiotic-resistant infections may soon have new treatment options. Researchers have identified a viral enzyme that disables bacterial defenses. This enzyme, produced by phage T7, uses pervasive phosphorylation to neutralize bacterial defenses. The discovery suggests that these viruses, often found in the gut, have evolved sophisticated strategies to evade bacterial immune systems.

The enzyme's ability to disarm bacterial defenses opens new avenues for developing therapies against superbugs. Bioengineer.org and Mirage News detail how phage contingency loci allow viruses to adapt to bacterial defenses. Euronews.com and EurekAlert! discuss the potential of these gut viruses in combating antibiotic resistance. Nature provides the technical details of the phosphorylation process.

The key question is how this viral mechanism can be harnessed for medical use. Researchers are exploring ways to leverage this discovery to create effective treatments. The focus is on understanding the mutation hotspots that enable these viruses to outmaneuver bacteria, as described by EurekAlert!.